Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also developing lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR 1-3), platelet-derived growth factor receptors alpha and beta (PDGFRa/), and fibroblast growth factor receptors 1 through 3 (FGFR 1-3); and FAP-2286, an investigational peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein. The company sells its Rubraca through a limited number of specialty distributor and specialty pharmacy providers, who subsequently sells Rubraca to patients and health care providers. Clovis Oncology, Inc. has license agreements with Pfizer Inc., AstraZeneca UK Limited, Advenchen Laboratories LLC, and 3B Pharmaceuticals GmbH, a clinical collaboration with Bristol Myers Squibb Company; and a partnership with Foundation Medicine, Inc. The company was incorporated in 2009 and is headquartered in Boulder, Colorado. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MUEHL DANIEL W | See Remarks | May 02 | Sale | 1.97 | 4,570 | 9,002 | 85,439 | May 03 04:15 PM | IVERS-READ GILLIAN C | See Remarks | May 02 | Sale | 1.97 | 3,733 | 7,353 | 276,220 | May 03 04:15 PM | Gross Paul Edward | See Remarks | May 02 | Sale | 1.97 | 4,570 | 9,002 | 79,393 | May 03 04:15 PM | Rolfe Lindsey | See Remarks | May 02 | Sale | 1.97 | 4,252 | 8,376 | 98,327 | May 03 04:15 PM | Harding Thomas C. | See Remarks | May 02 | Sale | 1.97 | 76 | 150 | 2,936 | May 03 04:15 PM | Harding Thomas C. | See Remarks | May 02 | Sale | 1.97 | 1,700 | 3,349 | 12,429 | May 03 04:15 PM | Harding Thomas C. | See Remarks | Apr 04 | Sale | 2.66 | 7 | 19 | 2,831 | Apr 05 04:16 PM | Gross Paul Edward | See Remarks | Mar 02 | Sale | 1.87 | 10,706 | 19,977 | 66,444 | Mar 03 04:15 PM | Rolfe Lindsey | See Remarks | Mar 02 | Sale | 1.87 | 10,945 | 20,423 | 86,817 | Mar 03 04:15 PM | MUEHL DANIEL W | See Remarks | Mar 02 | Sale | 1.87 | 10,706 | 19,977 | 72,490 | Mar 03 04:16 PM | Harding Thomas C. | See Remarks | Mar 02 | Sale | 1.87 | 880 | 1,642 | 1,662 | Mar 03 04:15 PM | Harding Thomas C. | See Remarks | Mar 02 | Sale | 1.87 | 6,946 | 12,961 | 6,850 | Mar 03 04:15 PM | IVERS-READ GILLIAN C | See Remarks | Mar 02 | Sale | 1.87 | 10,770 | 20,097 | 264,308 | Mar 03 04:15 PM | Rolfe Lindsey | See Remarks | Feb 02 | Sale | 1.94 | 4,514 | 8,756 | 84,357 | Feb 03 04:17 PM | MUEHL DANIEL W | See Remarks | Feb 02 | Sale | 1.94 | 5,436 | 10,544 | 70,045 | Feb 03 04:15 PM | Harding Thomas C. | See Remarks | Feb 02 | Sale | 1.94 | 81 | 157 | 1,652 | Feb 03 04:15 PM | Harding Thomas C. | See Remarks | Feb 02 | Sale | 1.94 | 2,037 | 3,951 | 6,015 | Feb 03 04:15 PM | IVERS-READ GILLIAN C | See Remarks | Feb 02 | Sale | 1.94 | 4,442 | 8,616 | 261,802 | Feb 03 04:16 PM | Gross Paul Edward | See Remarks | Feb 02 | Sale | 1.94 | 5,436 | 10,544 | 63,999 | Feb 03 04:15 PM | Harding Thomas C. | See Remarks | Jan 03 | Sale | 2.75 | 7 | 19 | 1,551 | Jan 04 04:15 PM | IVERS-READ GILLIAN C | See Remarks | Dec 02 | Sale | 3.00 | 304 | 912 | 260,041 | Dec 03 04:15 PM | Harding Thomas C. | See Remarks | Dec 02 | Sale | 3.00 | 7 | 21 | 1,542 | Dec 03 04:15 PM | Harding Thomas C. | See Remarks | Dec 02 | Sale | 3.00 | 141 | 423 | 5,395 | Dec 03 04:15 PM | MUEHL DANIEL W | See Remarks | Dec 02 | Sale | 3.00 | 248 | 744 | 67,403 | Dec 03 04:16 PM | Rolfe Lindsey | See Remarks | Dec 02 | Sale | 3.00 | 346 | 1,038 | 82,628 | Dec 03 04:16 PM | Gross Paul Edward | See Remarks | Dec 02 | Sale | 3.00 | 248 | 744 | 61,357 | Dec 03 04:15 PM | Rolfe Lindsey | See Remarks | Nov 02 | Sale | 4.55 | 4,209 | 19,151 | 79,987 | Nov 03 04:18 PM | IVERS-READ GILLIAN C | See Remarks | Nov 02 | Sale | 4.55 | 3,696 | 16,817 | 257,074 | Nov 03 04:19 PM | Harding Thomas C. | See Remarks | Nov 02 | Sale | 4.55 | 62 | 282 | 1,531 | Nov 03 04:15 PM | Harding Thomas C. | See Remarks | Nov 02 | Sale | 4.55 | 1,682 | 7,653 | 4,346 | Nov 03 04:15 PM | MUEHL DANIEL W | See Remarks | Nov 02 | Sale | 4.55 | 4,523 | 20,580 | 64,505 | Nov 03 04:15 PM | Gross Paul Edward | See Remarks | Nov 02 | Sale | 4.55 | 4,523 | 20,580 | 58,459 | Nov 03 04:15 PM | Harding Thomas C. | See Remarks | Oct 04 | Sale | 4.41 | 6 | 26 | 1,412 | Oct 05 04:31 PM | Harding Thomas C. | See Remarks | Sep 02 | Sale | 4.89 | 7 | 34 | 1,403 | Sep 03 05:21 PM | Harding Thomas C. | See Remarks | Sep 02 | Sale | 4.89 | 141 | 689 | 3,563 | Sep 03 05:21 PM | IVERS-READ GILLIAN C | See Remarks | Sep 02 | Sale | 4.89 | 304 | 1,487 | 254,980 | Sep 03 04:15 PM | Rolfe Lindsey | See Remarks | Sep 02 | Sale | 4.89 | 347 | 1,697 | 78,122 | Sep 03 04:15 PM | Gross Paul Edward | See Remarks | Sep 02 | Sale | 4.89 | 249 | 1,218 | 55,318 | Sep 03 04:15 PM | MUEHL DANIEL W | See Remarks | Sep 02 | Sale | 4.89 | 249 | 1,218 | 61,364 | Sep 03 04:16 PM | IVERS-READ GILLIAN C | See Remarks | Aug 03 | Sale | 4.82 | 3,683 | 17,752 | 252,005 | Aug 03 09:40 PM | Harding Thomas C. | See Remarks | Aug 03 | Sale | 4.82 | 62 | 299 | 1,391 | Aug 03 09:38 PM | Harding Thomas C. | See Remarks | Aug 03 | Sale | 4.82 | 1,678 | 8,088 | 2,511 | Aug 03 09:38 PM | MUEHL DANIEL W | See Remarks | Aug 03 | Sale | 4.82 | 4,507 | 21,724 | 58,459 | Aug 03 09:36 PM | Rolfe Lindsey | See Remarks | Aug 03 | Sale | 4.82 | 4,195 | 20,220 | 75,473 | Aug 03 09:32 PM | Gross Paul Edward | See Remarks | Aug 03 | Sale | 4.82 | 4,507 | 21,724 | 52,413 | Aug 03 09:31 PM | Harding Thomas C. | See Remarks | Jul 01 | Sale | 5.79 | 26 | 151 | 1,272 | Jul 06 04:16 PM | Gross Paul Edward | See Remarks | Jun 03 | Sale | 5.63 | 231 | 1,301 | 49,262 | Jun 03 07:03 PM | MUEHL DANIEL W | See Remarks | Jun 03 | Sale | 5.63 | 231 | 1,301 | 55,308 | Jun 03 07:01 PM | Rolfe Lindsey | See Remarks | Jun 03 | Sale | 5.63 | 322 | 1,813 | 73,602 | Jun 03 07:00 PM | IVERS-READ GILLIAN C | See Remarks | Jun 03 | Sale | 5.63 | 283 | 1,593 | 249,905 | Jun 03 06:58 PM | Harding Thomas C. | See Remarks | Jun 03 | Sale | 5.63 | 7 | 39 | 1,235 | Jun 03 06:57 PM | Harding Thomas C. | See Remarks | Jun 03 | Sale | 5.63 | 131 | 738 | 1,725 | Jun 03 06:57 PM |
|